If you don’t want to pay indefinitely for Microsoft 365, then replace it. Microsoft Office Home and Business 2024 doesn’t require a subscription, works for Mac or PC, and comes with many of the same ...
S&P Global Ratings said it expects to cut Electronic Arts Inc.’s credit grades to junk status after the video-game maker’s buyout deal is closed, citing the expected addition of about $20 billion of ...
German aviation group Lufthansa is cutting 4,000 administrative jobs over the next five years as it seeks to raise profitability targets. By 2030, Lufthansa, which operates the core Lufthansa German ...
CCleaner has long been a classic among Windows system optimizers, and next year the much-loved tool will celebrate its 20th anniversary. It has such an enduring legacy and has been so popular that ...
TotalEnergies TTE-0.48%decrease; red down pointing triangle said it will boost oil and gas production through 2030 while starting a $7.5 billion savings plan, days after cutting its quarterly buyback ...
Parth is a technology analyst and writer specializing in the comprehensive review and feature exploration of the Android ecosystem. His work is distinguished by its meticulous focus on flagship ...
Borrowing money can be stressful. But doing so via a product that has a variable interest rate adds another layer of concern. What about now, though? Inflation is significantly lower than it was just ...
Spotify on Thursday announced a series of updates to its AI policy, designed to better indicate when AI is being used to make music, to cut down on spam, and to make it clearer that unauthorized voice ...
Yakuza 0 Director’s Cut is the definitive edition of the critically acclaimed prequel to the Yakuza series. Fight like hell through Tokyo and Osaka entertainment districts as yakuza Kazuma Kiryu and ...
The One Big Beautiful Bill Act made permanent the individual tax cuts from President Trump’s first term and augmented them with additional tax cuts. The average taxpayer in every part of the country ...
Shares of Merck & Co. Inc. slumped Tuesday, after the drug giant reported a rare revenue miss amid disappointing sales of two of its three biggest drugs and announced a $3 billion cost-cutting plan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results